A detailed history of Vontobel Holding Ltd. transactions in Sutro Biopharma, Inc. stock. As of the latest transaction made, Vontobel Holding Ltd. holds 25,000 shares of STRO stock, worth $37,500. This represents 0.0% of its overall portfolio holdings.

Number of Shares
25,000
Previous 15,000 66.67%
Holding current value
$37,500
Previous $51,000 9.8%
% of portfolio
0.0%
Previous 0.0%

Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Jan 29, 2025

BUY
$1.82 - $4.4 $18,200 - $44,000
10,000 Added 66.67%
25,000 $46,000
Q1 2024

May 10, 2024

SELL
$3.27 - $5.65 $2.05 Million - $3.54 Million
-626,684 Reduced 97.66%
15,000 $84,000
Q4 2023

Jun 03, 2024

BUY
$2.07 - $4.54 $396,084 - $868,706
191,345 Added 42.49%
641,684 $2.75 Million
Q4 2023

Jan 29, 2024

BUY
$2.07 - $4.54 $396,084 - $868,706
191,345 Added 42.49%
641,684 $2.75 Million
Q3 2023

Jun 03, 2024

BUY
$3.29 - $4.9 $114,139 - $169,995
34,693 Added 8.35%
450,339 $1.56 Million
Q3 2023

Oct 10, 2023

BUY
$3.29 - $4.9 $114,139 - $169,995
34,693 Added 8.35%
450,339 $1.56 Million
Q2 2023

Jun 03, 2024

BUY
$4.25 - $5.88 $1.71 Million - $2.37 Million
402,646 Added 3097.28%
415,646 $1.93 Million
Q2 2023

Jul 24, 2023

BUY
$4.25 - $5.88 $1.71 Million - $2.37 Million
402,646 Added 3097.28%
415,646 $1.93 Million
Q1 2023

Jun 03, 2024

SELL
$4.48 - $8.45 $8,960 - $16,900
-2,000 Reduced 13.33%
13,000 $60,000
Q1 2023

Apr 12, 2023

BUY
$4.48 - $8.45 $13,440 - $25,349
3,000 Added 30.0%
13,000 $60,000
Q4 2022

Feb 14, 2023

BUY
$5.41 - $8.08 $54,100 - $80,800
10,000 New
10,000 $80,000

Others Institutions Holding STRO

About SUTRO BIOPHARMA, INC.


  • Ticker STRO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 52,161,500
  • Market Cap $78.2M
  • Description
  • Sutro Biopharma, Inc. operates as clinical stage drug discovery, development, and manufacturing company. It focuses on creating protein therapeutics for cancer and autoimmune disorders through integrated cell-free protein synthesis and site-specific conjugation platform, XpressCF+.The company's product candidates include STRO-001, an antibody-dr...
More about STRO
Track This Portfolio

Track Vontobel Holding Ltd. Portfolio

Follow Vontobel Holding Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Vontobel Holding Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Vontobel Holding Ltd. with notifications on news.